Stevens-Johnson Syndrome — SCE Infectious Diseases MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: B — Stevens-Johnson syndrome (SJS) secondary to Co-trimoxazole
Target lesions with mucosal involvement (≥2 mucosal sites) and skin detachment <10% BSA following sulfonamide exposure is classic SJS. Co-trimoxazole (Trimethoprim-Sulfamethoxazole) is one of the most commonly implicated drugs for SJS/TEN. Management includes immediate discontinuation of the causative drug, supportive care in a burns or dermatology unit, and consideration of IVIG or Ciclosporin. SJS is defined as <10% BSA detachment; TEN is >30%; overlap is 10–30%.
Reference: BAD 2023 – SJS/TEN guidelines; BNF 2024 – Co-trimoxazole adverse effects